132 results on '"Hubbard, Richard C."'
Search Results
2. Parecoxib Sodium does not Impair Platelet Function in Healthy Elderly and Non-Elderly Individuals: Two Randomised, Controlled Trials
3. A clinical trial demonstrates the analgesic activity of intravenous parecoxib sodium compared with ketorolac or morphine after gynecologic surgery with laparotomy
4. Parecoxib Sodium, an Injectable COX-2-Specific Inhibitor, Does Not Affect Unfractionated Heparin-Regulated Blood Coagulation Parameters
5. Efficacy and safety of the cyclooxygenase 2 inhibitors parecoxib and valdecoxib in patients undergoing coronary artery bypass surgery
6. Strategies for aerosol therapy ofα 1-antitrypsin deficiency by the aerosol route
7. A Pharmacokinetic Study of Intramuscular (IM) Parecoxib Sodium in Normal Subjects
8. A preliminary study of aerosolized recombinant human deoxyribonuclease I in the treatment of cystic fibrosis
9. Single doses of parecoxib sodium intravenously are as effective as ketorolac in reducing pain after oral surgery
10. Treatment of Osteoarthritis with a Once-Daily Dosing Regimen of Celecoxib: A Randomized, Controlled Trial
11. Effects of Celecoxib, a Novel Cyclooxygenase-2 Inhibitor, on Platelet Function in Healthy Adults: A Randomized, Controlled Trial
12. Celecoxib versus diclofenac in long-term management of rheumatoid arthritis: randomised double-blind comparison
13. Anti-inflammatory and Upper Gastrointestinal Effects of Celecoxib in Rheumatoid Arthritis: A Randomized Controlled Trial
14. Treatment of Osteoarthritis With Celecoxib, a Cyclooxygenase-2 Inhibitor: A Randomized Controlled Trial
15. PRELIMINARY STUDY OF THE SAFETY AND EFFICACY OF SC-58635, A NOVEL CYCLOOXYGENASE 2 INHIBITOR: Efficacy and Safety in Two Placebo-Controlled Trials in Osteoarthritis and Rheumatoid Arthritis, and Studies of Gastrointestinal and Platelet Effects
16. Upper GI mucosal effects of parecoxib sodium in healthy elderly subjects
17. Upper gastrointestinal safety evaluation of parecoxib sodium, a new parenteral cyclooxygenase-2—specific inhibitor, compared with ketorolac, naproxen, and placebo
18. A double-blind, randomized comparison of intramuscularly and intravenously administered parecoxib sodium versus ketorolac and placebo in a post—oral surgery pain model
19. Comparison of once-daily and twice-daily administration of celecoxib for the treatment of osteoarthritis of the knee
20. Aerosolized Recombinant Human Deoxyribonuclease I in the Treatment of Cystic Fibrosis
21. Augmentation of Functional Prostaglandin E Levels on the Respiratory Epithelial Surface by Aerosol Administration of Prostaglandin E
22. Aerosol alpha-1-antitrypsin treatment for cystic fibrosis
23. Anti-inflammatory and Upper Gastrointestinal Effects of Celecoxib in Rheumatoid Arthritis:A Randomized Controlled Trial
24. Leptospirosis Epizootic among California Sea Lions
25. Glutathione Deficiency in the Epithelial Lining Fluid of the Lower Respiratory Tract in Idiopathic Pulmonary Fibrosis
26. Evaluation of the S-type of Alpha-1-Antitrypsin as an In Vivo and In Vitro Inhibitor of Neutrophil Elastase
27. Anti-Neutrophil-Elastase Defenses of the Lower Respiratory Tract in α1-Antitrypsin Deficiency Directly Augmented with an Aerosol of α1-Antitrypsin
28. Effect of glutathione aerosol on oxidant-antioxidant imbalance in idiopathic pulmonary fibrosis
29. Anti-neutrophil-elastase defenses of the lower respiratory tract in alpha 1-antitrypsin deficiency directly augmented with an aerosol of alpha 1-antitrypsin
30. PARECOXIB VERSUS IBUPROFEN: Author's response
31. Parecoxib Sodium Demonstrates Gastrointestinal Safety Comparable to Placebo in Healthy Subjects
32. Analgesic Efficacy of Preoperative Parecoxib Sodium in an Orthopedic Pain Model
33. Parecoxib Sodium, a Parenteral Cyclooxygenase 2 Selective Inhibitor, Improves Morphine Analgesia and Is Opioid-sparing following Total Hip Arthroplasty
34. Efficacy and Safety of Intravenous Parecoxib Sodium in Relieving Acute Postoperative Pain following Gynecologic Laparotomy Surgery
35. The Injectable Cyclooxygenase-2-Specific Inhibitor Parecoxib Sodium Has Analgesic Efficacy When Administered Preoperatively
36. Reduced incidence of gastroduodenal ulcers with valdecoxib compared to ibuprofen and diclofenac in patients with osteoarthritis: A multicenter trial
37. Reduced Risk of Upper Gastrointestinal Ulcer Complications With Celecoxib, A Novel Cox-2 Inhibitor
38. Celecoxib Does Not Significantly Alter the Pharmacokinetics or Hypoprothrombinemic Effect of Warfarin in Healthy Subjects
39. An endoscopic study of the gastroduodenal effects of SC-69124A, a parenteral COX-2-specific inhibitor, in the elderly
40. Conversion from Twice-to Once-Daily Extended-Release Theophylline Treatment in Patients with Reversible Airway Obstruction
41. Augmentation of Functional Prostaglandin E Levels on the Respiratory Epithelial Surface by Aerosol Administration of Prostaglandin E
42. Use of a Highly Purified α1-Antitrypsin Standard to Establish Ranges for the Common Normal and Deficient α1-Antitrypsin Phenotypes
43. Antiproteases and Antioxidants: Strategies for the Pharmacologic Prevention of Lung Destruction.
44. Recombinant secretory leukoprotease inhibitor augments glutathione levels in lung epithelial lining fluid.
45. Aerosolization of recombinant SLPI to augment antineutrophil elastase protection of pulmonary epithelium.
46. Normal alveolar epithelial lining fluid contains high levels of glutathione.
47. Treatment of Osteoarthritis with a OnceDaily Dosing Regimen of Celecoxib A Randomized, Controlled Trial
48. The Alpha1-antitrypsin Gene and Its Mutations
49. Glutathione Deficiency in the Epithelial Lining Fluid of the Lower Respiratory Tract in Idiopathic Pulmonary Fibrosis
50. Alpha-1-antitrypsin augmentation therapy for alpha-1-antitrypsin deficiency
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.